The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks

NARecruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

October 1, 2027

Conditions
Hallux ValgusAnesthesia
Interventions
DRUG

0.25% ropivacaine

A total of 15 ml of 0.25% ropivacaine will be administered and distributed strategically among the specific nerves: 6 ml for the tibial nerve, 3 ml for the deep peroneal nerve, and 2 ml each for the superficial peroneal nerve, saphenous nerve, and sural nerve.

DRUG

0.5% ropivacaine

A total of 15 ml of 0.5% ropivacaine will be administered and distributed strategically among the specific nerves: 6 ml for the tibial nerve, 3 ml for the deep peroneal nerve, and 2 ml each for the superficial peroneal nerve, saphenous nerve, and sural nerve.

DRUG

1% ropivacaine

A total of 15 ml of 1% ropivacaine will be administered and distributed strategically among the specific nerves: 6 ml for the tibial nerve, 3 ml for the deep peroneal nerve, and 2 ml each for the superficial peroneal nerve, saphenous nerve, and sural nerve.

Trial Locations (1)

3600

RECRUITING

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER